APA-viite (7. p.)

Smyth, D., Croker, R., & Goldacre, B. (2018). Pregabalin: What the patent litigation means for doctors and drug companies. BMJ Publishing Group.

Chicago-viite (17. p.)

Smyth, D., R. Croker, ja B. Goldacre. Pregabalin: What the Patent Litigation Means for Doctors and Drug Companies. BMJ Publishing Group, 2018.

MLA-viite (9. p.)

Smyth, D., et al. Pregabalin: What the Patent Litigation Means for Doctors and Drug Companies. BMJ Publishing Group, 2018.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.